Study partner‐reported decline identifies cognitive decline and dementia risk

by Rachel L. Nosheny, Chengshi Jin, John Neuhaus, Philip S. Insel, Robert Scott Mackin, Michael W. Weiner, Alzheimer’s Disease Neuroimaging Initiative investigators
Published 2019-12-01

Assessing risk for preclinical β‐amyloid pathology with APOE, cognitive, and demographic information

by Philip S. Insel, Sebastian Palmqvist, R. Scott Mackin, Rachel L. Nosheny, Oskar Hansson, Michael W. Weiner, Niklas Mattsson, Alzheimer's Disease Neuroimaging Initiative
Published 2016-01-01

Predicting amyloid status using self‐report information from an online research and recruitment registry: The Brain Health Registry

by Miriam T. Ashford, John Neuhaus, Chengshi Jin, Monica R. Camacho, Juliet Fockler, Diana Truran, R. Scott Mackin, Gil D. Rabinovici, Michael W. Weiner, Rachel L. Nosheny
Published 2020-01-01

An Anti-β-Amyloid Vaccine for Treating Cognitive Deficits in a Mouse Model of Down Syndrome.

by Pavel V Belichenko, Rime Madani, Lorianne Rey-Bellet, Maria Pihlgren, Ann Becker, Adeline Plassard, Stephanie Vuillermot, Valérie Giriens, Rachel L Nosheny, Alexander M Kleschevnikov, Janice S Valletta, Sara K S Bengtsson, Gordon R Linke, Michael T Maloney, David T Hickman, Pedro Reis, Anne Granet, Dorin Mlaki, Maria Pilar Lopez-Deber, Long Do, Nishant Singhal, Eliezer Masliah, Matthew L Pearn, Andrea Pfeifer, Andreas Muhs, William C Mobley
Published 2016-01-01